Patients with leptin deficiency have been observed to develop obesity and hyperphagia in childhood, prompting the consideration of leptin replacement therapy to suppress appetite and increase energy expenditure. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.